Valion Bio agrees to sell 1,500 Series B preferred shares to 3i for $1.5 million in private placementPUBT·1 day ago, 05:26 AMVBIO-12.00%III
VBIO: Net loss widened on higher R&D and CDMO costs, with urgent need for new funding and Nasdaq compliance risksQuartr·Aug 14 at 04:51 PMVBIO-12.00%
Valion Bio Q2 net loss widens to $7.1 million; operating loss deepens to $6.4 millionPUBT·Aug 14 at 04:34 PMVBIO-12.00%
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga_article·Aug 13 at 12:05 PMBYSI+0.93%OMER-0.98%
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga_article·Aug 13 at 07:05 AMABEO+3.70%NRC+1.10%
Why Omeros Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarketbenzinga_article·Aug 13 at 04:16 AMSFHG-4.78%OMER-0.98%
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga_article·Aug 12 at 04:06 PMVBIO-12.00%OTLK+4.14%
Valion Bio Announces U.S. Government-Funded Entolimod Studies Targeting Lethal Radiation-Induced GI Injury | VBIO Stock NewsStockTitan·Aug 12 at 12:29 AMVBIO-12.00%
Valion Bio issues 1,287 Series A preferred shares in unregistered sale tied to $750,000 milestone paymentPUBT·Aug 6 at 03:51 PMVBIO-12.00%
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga_article·Jul 24 at 04:05 PMITOC+3.26%SXTC+36.80%
World-Premier Cancer Center Sheba Medical Center Selects Entolimod for Clinical Trial, Potentially Expanding Valion Bio into the Multi-Billion-Dollar Neutropenia Market | VBIO Stock NewsStockTitan·Jul 20 at 04:28 AMVBIO-12.00%
